Jivi Design Guide

Listing Results Jivi Design Guide

About 15 results and 4 answers.

Jivi: Study Designs

Jivi vs rurioctocog alfa pegol head-to-head PK comparison 2. The 50 IU/kg doses administered in this study were calculated based on the nominal potencies (1000 IU) as provided on the label …

Show more

See More

JIVI FDA

Jivi, antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age …

Show more

See More

Jivi Why Jivi - Bayer

In the first head-to-head crossover study, Jivi demonstrated a superior PK profile vs. rFVIII-Fc 4 Study design: Phase 1, open-label, crossover study to directly compare the …

Show more

See More

Jivi Dosage Guide - Drugs.com

A guide for dosing Jivi for the on-demand treatment and control of bleeding episodes is provided in Table 1. The goal of treatment is to maintain a plasma Factor VIII …

Show more

See More

Home

Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Jivi is used to treat and control bleeding in …

Show more

See More

Jivi® Official Healthcare Professionals Site

Jivi antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age …

Show more

See More

Jivi - FDA prescribing information, side effects and uses

A guide for dosing Jivi for the on-demand treatment and control of bleeding episodes is provided in Table 1. The goal of treatment is to maintain a plasma Factor VIII …

Show more

See More

Џиви - Jivi

ЏИВИ ДОО Гевгелија е компанија основана во 1992 година, кога започна со трговија на аудио-видео опрема и апарати за домаќинство. Од самиот почеток ЏИВИ остварува …

Show more

See More

Jivi , PEGylated-aucl

Sep 07, 2018 . A guide for dosing Jivi for the on-demand treatment and control of bleeding episodes is provided in Table 1. The goal of treatment is to maintain a plasma Factor VIII …

Show more

See More

Jivi European Medicines Agency

Jivi is a medicine used to treat and prevent bleeding in patients with haemophilia A, an inherited bleeding disorder caused by lack of a clotting protein called factor VIII. Jivi can …

Show more

See More

Jivi - Leaping Bunny

Compassionate Shopping Guide Cruelty Free App Company Deals Where to Buy Merchandise About Who We Are ... Jivi. Website. Visit Company Website. Countries this brand …

Show more

See More

Monitoring Jivi® antihemophilic factor (recombinant

Jivi antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age …

Show more

See More

Frequently Asked Questions

  • What is Jivi and how does it work?

    The active substance in Jivi, damoctocog alfa pegol, works in the same way as the body’s factor VIII. It replaces the missing factor VIII, thereby helping the blood to clot and giving temporary control of the bleeding disorder.

  • How do I contact the FDA about Jivi antihemophilic factor?

    Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Jivi antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age and older) with hemophilia A (congenital Factor VIII deficiency) for:

  • Is Jivi authorised in the European Union?

    This medicine is authorised for use in the European Union. Jivi is a medicine used to treat and prevent bleeding in patients with haemophilia A, an inherited bleeding disorder caused by lack of a clotting protein called factor VIII.

  • What is the age limit for Jivi?

    Learn about possible savings and co-pay support for Jivi®. EHL, extended half-life; rFVIII, recombinant Factor VIII. Jivi is not indicated for use in children less than 12 years of age due to a greater risk for hypersensitivity reactions. Jivi is not indicated for use in previously untreated patients (PUPs).

Have feedback?

If you have any questions, please do not hesitate to ask us.